Back to announcement
20260627_MMIX_Ringkasan Risalah//Risalah RUPS_32105176_lamp1.pdf
RUPS minutes Parsed MMIXSource file signed link, expires in 15 minutes
Extracted text 9
Page 1
PT. MULTI MEDIKA INTERNASIONAL, Tbk.
PENGUMUMAN RINGKASAN RISALAH
RAPAT UMUM PEMEGANG SAHAM TAHUNAN
PT MULTI MEDIKA INTERNASIONAL, Tbk
PT MULTI MEDIKA INTERNASIONAL, Tbk, perseroan terbatas yang telah mencatatkan seluruh
sahamnya di Bursa Efek Indonesia, berkedudukan di Kota Jakarta Barat (selanjutnya disebut dengan
“Perseroan”) dengan ini mengumumkan kepada seluruh Pemegang Saham Perseroan, bahwa pada hari,
Jumat, tanggal 26 Juni 2026, Perseroan telah mengadakan Rapat Umum Pemegang Saham Luar Tahunan
(selanjutnya disebut “Rapat”).
Sebagaimana diatur dalam Pasal 49 Peraturan Otoritas Jasa Keuangan No. 15/POJK.04/2020 tentang
Rencana dan Penyelenggaraan Rapat Umum Pemegang Saham Perusahaan Terbuka tanggal 20 April
2020 ("Peraturan OJK No. 15”), Perseroan diwajibkan untuk membuat ringkasan risalah Rapat, sesuai
dengan risalah Rapat yang dituangkan dalam Akta Berita Acara Rapat Umum Pemegang Saham Tahunan
PT Multi Medika Internasional, Tbk No. 123 tanggal 26 Juni 2026, yang dibuat oleh Dr. Sugih Haryati, SH,
M.Kn Notaris di Jakarta Selatan, sebagai berikut:
1. Lokasi, tempat dan tanggal:
• Hari dan Tanggal Rapat : Jumat, 26 Juni 2026
• Tempat penyelenggaraan Rapat : Apartemen Royal Mediterania Garden
Residence, Ruang Balai Warga Lantai LG, Jl. Jenderal
S Parman Kaveling 28, Kelurahan Tanjung Duren
Selatan, Kecamatan Grogol Petamburan, Jakarta Barat
& Fasilitas Electronic General Meeting System
(‘eASY.KSEI’)
• Waktu penyelenggaraan Rapat : Pukul 16.05 WIB s/d 16.51 WIB
2. Mata Acara Rapat:
1. Persetujuan Laporan Tahunan Perseroan termasuk Laporan Keuangan dan Laporan Tugas
Pengawasan Dewan Komisaris untuk Tahun Buku yang berakhir pada tanggal 31 Desember 2025;
2. Persetujuan dan Penetapan Penggunaan Laba Bersih Perseroan untuk Tahun Buku yang berakhir
pada Tanggal 31 Desember 2025
3. Penetapan Gaji atau honorarium dan tunjangan untuk tahun buku 2026 serta tantiem untuk tahun
buku 2025 kepada anggota Direksi dan Dewan Komisaris Perseroan
4. Penunjukan Akuntan Publik dan/atau Kantor Akuntan Publik untuk mengaudit laporan keuangan
Perseroan untuk tahun buku yang berakhir pada tanggal 31 Desember 2026
5. Persetujuan penyesuaian KBLI Perseroan menjadi Kode KBLI tahun 2025.
3. - Anggota Direksi Perseroan yang hadir pada saat Rapat:
Direktur Utama Mengky Mangarek
Direktur Eveline Natalia Susanto
Page 2
PT. MULTI MEDIKA INTERNASIONAL, Tbk.
Anggota Dewan Komisaris Perseroan yang hadir pada saat Rapat:
Komisaris Utama Allen Feliciano (dilakukan secara daring)
Komisaris Independen Togu Cornetius Simanjuntak
4. Jumlah saham dengan hak suara yang sah yang hadir pada saat Rapat adalah 3.372.014.400 (tiga
miliar tiga ratus tujuh puluh dua juta empat belas ribu empat ratus) saham atau setara dengan 70,24%
(tujuh puluh koma dua empat persen) dari jumlah seluruh saham yang mempunyai hak suara yang
sah yang telah dikeluarkan oleh Perseroan.
Bahwa kuorum kehadiran yang dipersyaratkan untuk penyelenggaraan Rapat dan pelaksanaan mata
acara Rapat Pertama, Kedua, Ketiga, dan Keempat berdasarkan Pasal 23 ayat 1 huruf a angka (i)
Anggaran Dasar juncto Pasal 41 ayat 1 huruf a Peraturan OJK No. 15/POJK.04/2020, adalah bahwa
Rapat dihadiri oleh Pemegang Saham dan kuasa pemegang saham yang mewakili lebih dari 1/2 (satu
per dua) bagian dari seluruh saham dengan hak suara hadir atau diwakili, sedangkan untuk mata
acara Rapat Kelima berdasarkan Pasal 23 ayat 1 huruf b angka Anggaran Dasar juncto Pasal 42
huruf a Peraturan OJK No. 15/POJK.04/2020, adalah bahwa Rapat dihadiri oleh Pemegang Saham
dan kuasa pemegang saham yang mewakili lebih dari 2/3 (dua per tiga) bagian dari seluruh saham
dengan hak suara hadir atau diwakilidan oleh karenanya kuorum kehadiran untuk seluruh mata acara
Rapat telah terpenuhi, dan demikian Rapat ini adalah sah dan berhak serta berwenang untuk
membicarakan dan mengambil keputusan yang sah dan mengikat
5. Kepada Pemegang Saham diberikan kesempatan untuk mengajukan pertanyaan dan/atau
memberikan pendapat terkait setiap mata acara Rapat, untuk agenda rapat pertama ada pertanyaan,
akan tetapi tidak sesuai dengan agenda rapat sehingga tidak perlu dijawab oleh Direksi.
6. Hasil pengambilan keputusan yang dilakukan dengan pemungutan suara/voting dan
Keputusan Rapat adalah sebagai berikut:
i. Mata Acara Pertama
Tidak Setuju Setuju Abstain Total Setuju
(Suara Mayoritas +
Abstain)
0 suara/0 % 3.372.014.400 suara 0 suara/0 % 3.372.014.400 suara
/100% /100%
Page 3
PT. MULTI MEDIKA INTERNASIONAL, Tbk.
Keputusan Rapat:
Menyetujui Laporan Tahunan Perseroan Tahun Buku 2025, termasuk Laporan Tugas
Pengawasan Dewan Komisaris serta mengesahkan Laporan Keuangan Perseroan untuk Tahun
Buku 2025 yang telah diaudit oleh Kantor Akuntan Publik Hadori Sugiarto Adi & Rekan serta
memberikan pelunasan dan pembebasan tanggung jawab sepenuhnya (acquit et de charge)
kepada seluruh anggota Direksi Perseroan atas tindakan pengurusan serta kepada seluruh
anggota Dewan Komisaris Perseroan atas tindakan pengawasan selama tahun buku Perseroan
yang berakhir pada tanggal 31 Desember 2025, sepanjang tindakan tersebut tercermin dalam
buku laporan Perseroan dan bukan merupakan tindakan pidana
ii. Mata Acara Kedua
Tidak Setuju Setuju Abstain Total Setuju
(Suara Mayoritas +
Abstain)
0 suara/0 % 3.372.014.400 suara 0 suara/0 % 3.372.014.400 suara
/100% /100%
Keputusan Rapat:
Menyetujui penggunaan Laba Bersih Perseroan tahun buku 2025 sebesar sebesar Rp
5.565.549.359,- (lima milyar lima ratus enam puluh lima juta lima ratus empat puluh sembilan ribu
tiga ratus lima puluh sembilan rupiah), sebagai berikut:
1. Sebesar Rp 3.500.000.000,- (tiga milyar lima ratus juta rupiah) akan dialokasikan dan
dibukukan sebagai dana cadangan;
Sedangkan akumulasi laba bersih sampai dengan tahun buku 2025 sebesar Rp
28.523.657.432,- (dua puluh delapan milyar lima ratus dua puluh tiga juta enam ratus lima
puluh tujuh ribu empat ratus tiga puluh dua rupiah) akan dibukukan sebagai laba ditahan,
untuk menambah modal kerja Perseroan
2. Memberikan kuasa dan wewenang kepada Direksi dan/atau Dewan Komisaris Perseroan
untuk melakukan semua dan setiap tindakan yang diperlukan sehubungan dengan keputusan
tersebut di atas, sesuai dengan peraturan perundang-undangan yang berlaku.
Page 4
PT. MULTI MEDIKA INTERNASIONAL, Tbk.
iii. Mata Acara Ketiga
Tidak Setuju Setuju Abstain Total Setuju
(Suara Mayoritas +
Abstain)
0 suara/0 % 3.372.014.400 suara 0 suara/0 % 3.372.014.400 suara
/100% /100%
Keputusan Rapat:
Menyetujui penetapan Gaji dan/atau honorarium dan/atau remunerasi dan/atau tunjangan
lainnya bagi masing-masing anggota Direksi dan anggota Dewan Komisaris perseroan serta
pemberian wewenang dan kuasa kepada Dewan Komisaris Perseroan untuk menetapkan gaji
dan/atau honorarium dan/atau remunerasi dan/atau tunjangan lainnya bagi masing-masing
anggota Direksi Perseroan dan Dewan Komisaris untuk tahun buku 2026 dan tantiem untuk tahun
buku 2025 kepada anggota Direksi dan Dewan Komisaris Perseroan
iv. Mata Acara Keempat;
Tidak Setuju Setuju Abstain Total Setuju
(Suara Mayoritas +
Abstain)
0 suara/0 % 3.372.014.400 suara 0 suara/0 % 3.372.014.400 suara
/100% /100%
Keputusan Rapat:
Menyetujui pemberian Kuasa kepada Dewan Komisaris Perseroan untuk menunjuk Kantor
Akuntan Publik untuk mengaudit atas buku-buku Perseroan untuk Tahun Buku yang akan berakhir
pada tanggal 31 Desember 2026 sekaligus memberikan kuasa kepada Direksi Perseroan untuk
menetapkan honorarium dan persyaratan-persyaratan lain sehubungan dengan penunjukan
Kantor Akuntan Publik tersebut
Page 5
PT. MULTI MEDIKA INTERNASIONAL, Tbk.
v. Mata Acara Kelima
Tidak Setuju Setuju Abstain Total Setuju
(Suara Mayoritas +
Abstain)
0 suara/0 % 3.372.014.400 suara 0 suara/0 % 3.372.014.400 suara
/100% /100%
Keputusan Rapat:
1. Menyetujui tindakan Perseroan untuk penyesuaian maksud dan tujuan serta kegiatan usaha
dalam anggaran dasar Perseroan, agar disesuaikan dengan KBLI 2025.
2. Menyetujui pemberian wewenang dan kuasa dengan hak substitusi kepada setiap anggota
Direksi Perseroan untuk melakukan segala tindakan sehubungan dengan penyesuaian kbli
perseroan menjadi kode kbli tahun 2025, sebagaimana disebutkan di atas, termasuk tetapi
tidak terbatas untuk membuat atau meminta untuk dibuatkan serta menandatangani segala
akta sehubungan dengan perubahan kode kbli untuk disesuaikan dengan kode kbli 2025,
tersebut dan untuk mendaftarkan penyesuaian kode kbli 2025 tersebut kepada instansi
pemerintah sesuai dengan ketentuan perundang-undangan yang berlaku.
Page 6
PT. MULTI MEDIKA INTERNASIONAL, Tbk.
ANNOUNCEMENT OF SUMMARY MINUTES OF
ANNUAL GENERAL MEETING OF SHAREHOLDERS
PT MULTI MEDIKA INTERNASIONAL, Tbk
PT MULTI MEDIKA INTERNASIONAL, Tbk, a limited liability company listed on the Indonesia Stock
Exchange, domiciled in West Jakarta (hereinafter referred to as the "Company"), hereby announces to all
Shareholders that on Friday, June 26, 2026, the Company held an Extraordinary Annual General Meeting
of Shareholders (hereinafter referred to as the "Meeting").
as regulated in Article 49 of Financial Services Authority Regulation No. Pursuant to OJK Regulation No.
15/POJK.04/2020 concerning the Planning and Implementation of the General Meeting of Shareholders of
Public Companies on April 20, 2020 ("OJK Regulation No. 15"), the Company is required to prepare a
summary of the minutes of the Meeting, in accordance with the minutes of the Meeting required in the Deed
of Minutes of the Annual General Meeting of Shareholders of PT Multi Medika Internasional, Tbk No. 123
dated June 26, 2026, drawn up by Dr. Sugih Haryati, SH, M.Kn, Notary in South Jakarta, as follows:
- Location, Venue, and Date:
• Meeting Day and Date : Friday, June 26, 2026
• Meeting Venue : Royal Mediterania Garden Apartment
Residence, Balai Warga Room, LG Floor, Jl. General S.
Parman, Kaveling 28, Tanjung Duren Selatan Village, Grogol
Petamburan District, West Jakarta & Electronic General Meeting
System (eASY.KSEI) Facilities
• Meeting Time : 4:05 PM WIB to 4:51 PM WIB
- Meeting Agenda:
1. Approval of the Company's Annual Report, including the Financial Statements and the Board
of Commissioners' Supervisory Report for the Fiscal Year ending December 31, 2025;
2. Approval and Determination of the Use of the Company's Net Profit for the Financial Year
Ending December 31, 2025
3. Determination of the Salaries or Honorariums and Allowances for the Financial Year 2026, as
well as Bonuses for the Financial Year 2025, for the members of the Company's Board of
Directors and Board of Commissioners.
4. Appointment of a Public Accountant and/or Public Accounting Firm to audit the Company's
financial statements for the financial year ending December 31, 2026.
5. Approval of the Adjustment of the Company's KBLI to the 2025 KBLI Code.
3. - Members of the Company's Board of Directors present at the Meeting:
President Director Mengky Mangarek
Director Eveline Natalia Susanto
Page 7
PT. MULTI MEDIKA INTERNASIONAL, Tbk.
Members of the Company's Board of Commissioners present at the Meeting:
President Commissioner Allen Feliciano (attending virtually)
Independent Commissioner Togu Cornetius Simanjuntak
4. The number of shares with valid voting rights present at the Meeting was 3,372,014,400 (three
billion three hundred and seventy-five thousand Rupiah). twenty-two million fourteen thousand four
hundred) shares or equivalent to 70.24% (seventy point two four percent) of the total number of
shares with valid voting rights issued by the Company.
That the attendance quorum required for holding the Meeting and implementing the First, Second,
Third, and Fourth Meeting agenda items based on Article 23 paragraph 1 letter a number (i) of the
Articles of Association in conjunction with Article 41 paragraph 1 letter a of OJK Regulation No.
15/POJK.04/2020, is that the Meeting is held by Shareholders and their proxies who are more than
1/2 (one half) of the total shares with voting rights present or vice versa, while for the Fifth Meeting
agenda item based on Article 23 paragraph 1 letter b number of the Articles of Association in
conjunction with Article 42 letter a of OJK Regulation No. In accordance with Article
15/POJK.04/2020, the Meeting was attended by Shareholders and their proxies representing more
than 2/3 (two-thirds) of the total shares with voting rights, and since the quorum for all Meeting
agenda items was present, the Meeting was valid and lawful.
5. Shareholders were given the opportunity to ask questions and/or provide opinions regarding each
Meeting agenda item. For the first meeting agenda item, there was a question, but it was not in
accordance with the meeting agenda and therefore did not require an answer from the Board of
Directors.
6. The results of the decision-making process, which was carried out by voting, and the Meeting
Resolutions are as follows:
i. First Agenda Item
Disagree Agree Abstain Total Agree
(Majority Vote + Abstain)
0 votes/0 % 3.372.014.400 votes 0 votes 0 % 3.372.014.400 votes
/100% /100%
Meeting Resolutions:
To approve the Company's Annual Report for the 2025 Financial Year, including the Board of
Commissioners' Supervisory Report, and to ratify the Company's Financial Statements for the
2025 Financial Year, audited by the Public Accounting Firm Hadori Sugiarto Adi & Rekan. To
grant full release and discharge (acquit et de charge) to all members of the Company's Board of
Page 8
PT. MULTI MEDIKA INTERNASIONAL, Tbk.
Directors for their actions, and to all members of the Company's Board of Commissioners for their
supervision during the Company's financial year ending December 31, 2025.
ii. Second Agenda
Disagree Agree Abstain Total Agree
(Majority Vote + Abstain)
0 votes/0 % 3.372.014.400 votes 0 votes 0 % 3.372.014.400 votes
/100% /100%
Meeting Resolutions:
To approve the use of the Company's Net Profit for the 2025 financial year in the amount of Rp
5,565,549,359 (five billion five hundred sixty-five million five hundred forty-nine thousand three
hundred fifty-nine rupiah), as follows:
1. Rp 3,500,000,000 (three billion five hundred million rupiah) will be allocated and recorded as
a reserve fund;
Meanwhile, the accumulated net profit up to the 2025 financial year of IDR 28,523,657,432
(twenty-eight billion five hundred twenty-three million six hundred fifty-seven thousand four
hundred and thirty-two rupiah) will be recorded as retained earnings to increase the
Company's working capital.
2. Granting power and authority to the Company's Board of Directors and/or Board of
Commissioners to take all and any necessary actions in connection with the aforementioned
decision, in accordance with applicable laws and regulations.
iii. Third Agenda Item
Disagree Agree Abstain Total Agree
(Majority Vote + Abstain)
0 votes/0 % 3.372.014.400 votes 0 votes 0 % 3.372.014.400 votes
/100% /100%
Meeting Resolutions:
To approve the determination of salaries and/or honorariums and/or remuneration and/or other
allowances for each member of the Company's Board of Directors and Board of Commissioners,
and to grant authority and power to the Company's Board of Commissioners to determine the
salaries and/or honorariums and/or remuneration and/or other allowances for each member of the
Company's Board of Directors and Board of Commissioners for the 2026 financial year and
bonuses for the 2025 financial year for each member of the Company's Board of Directors and
Board of Commissioners.
Page 9
PT. MULTI MEDIKA INTERNASIONAL, Tbk.
iv. Fourth Agenda Item;
Disagree Agree Abstain Total Agree
(Majority Vote + Abstain)
0 votes/0 % 3.372.014.400 votes 0 votes 0 % 3.372.014.400 votes
/100% /100%
Meeting Resolutions:
Approved the granting of power of attorney to the Company's Board of Commissioners to appoint
a Public Accounting Firm to audit the Company's books for the Financial Year ending December
31, 2026, and also authorized the Company's Board of Directors to determine the honorarium and
other requirements related to the appointment of the Public Accounting Firm.
v. Fifth Agenda Item
Disagree Agree Abstain Total Agree
(Majority Vote + Abstain)
0 votes/0 % 3.372.014.400 votes 0 votes 0 % 3.372.014.400 votes
/100% /100%
Meeting Resolutions:
1. Approved the Company's actions to adjust the purposes and objectives and business
activities in the Company's articles of association to align with the 2025 KBLI.
2. Approved the granting of authority and power with the right of substitution to each member
of the Company's Board of Directors to take all actions related to the adjustment of the
Company's KBLI to the 2025 KBLI code, as mentioned above, including but not limited to
preparing or requesting the preparation and signing of all deeds related to the change in the
KBLI code to align with the 2025 KBLI code and to register the adjustment to the 2025 KBLI
code with government agencies in accordance with applicable laws and regulations.
Jakarta, 29 Juni 2026
PT MULTI MEDIKA INTERNASIONAL Tbk
Direksi
RUPS extracted from this filing
| Emiten | |
| Type | RUPS Tahunan |
| Held | 26 Jun 2026 · 16:05–16:51 |
| Present | 3,372,014,400 (70.24%) |
| Chair | — |
Agenda 1
approved
For
3,372,014,400
100.00%
Against
0
0.00%
Abstain
0
0.00%
Agenda 2
approved
For
3,372,014,400
100.00%
Against
0
0.00%
Abstain
0
0.00%
Agenda 3
approved
For
3,372,014,400
100.00%
Against
0
0.00%
Abstain
0
0.00%
Agenda 4
approved
For
3,372,014,400
100.00%
Against
0
0.00%
Abstain
0
0.00%
Agenda 5
approved
For
3,372,014,400
100.00%
Against
0
0.00%
Abstain
0
0.00%
- Meeting Day and Date : Friday, June 26, 2026
- Meeting Venue : Royal Mediterania Garden Apartment
- Meeting Time : 4:05 PM WIB to 4:51 PM WIB
Names mentioned 13 people and organisations named in the text · linked when the evidence is strong
unresolved
person
Dr. Sugih Haryati
· Notaris
p.1 ×5
unresolved
person
Eveline Natalia Susanto
· Direktur
p.1 ×4
unresolved
person
Togu Cornetius Simanjuntak
· Komisaris Independen
p.2 ×2
unresolved
org
Kantor Akuntan Publik Hadori Sugiarto Adi & Rekan
p.3
unresolved
org
Kantor Akuntan Publik Hadori Sugiarto Adi
p.3
unresolved
org
Indonesia Stock Exchange
p.6
unresolved
org
Financial Services Authority
p.6
unresolved
org
Public Accounting Firm Hadori Sugiarto Adi & Rekan
p.7
Extraction attempts how the parser did, and what it refused
Rule parser
OK
confidence 1.000
1147 ms
12 Sep 2026 21:59
Raw output
{'agenda': [{'approved': True,
'pct_abstain': '0',
'pct_against': '0',
'pct_for': '100',
'pct_in_favor_total': '100',
'resolution_items': [],
'resolution_text': 'Menyetujui Laporan Tahunan Perseroan Tahun '
'Buku 2025, termasuk Laporan Tugas Pengawasan '
'Dewan Komisaris serta mengesahkan Laporan '
'Keuangan Perseroan untuk Tahun Buku 2025 yang '
'telah diaudit oleh Kantor Akuntan Publik '
'Hadori Sugiarto Adi & Rekan serta memberikan '
'pelunasan dan pembebasan tanggung jawab '
'sepenuhnya (acquit et de charge) kepada '
'seluruh anggota Direksi Perseroan atas '
'tindakan pengurusan serta kepada seluruh '
'anggota Dewan Komisaris Perseroan atas '
'tindakan pengawasan selama tahun buku '
'Perseroan yang berakhir pada tanggal 31 '
'Desember 2025, sepanjang tindakan tersebut '
'tercermin dalam buku laporan Perseroan dan '
'bukan merupakan tindakan pidana ii.',
'seq': 1,
'title': 'Persetujuan Laporan Tahunan Perseroan termasuk Laporan '
'Keuangan dan Laporan Tugas Pengawasan Dewan Komisaris '
'untuk Tahun Buku yang berakhir pada tanggal 31 Desember '
'2025; 2. Persetujuan dan Penetapan Penggunaan Laba '
'Bersih Perseroan untuk Tahun Buku yang berakhir pada '
'Tanggal 31 Desember 2025 3. Penetapan Gaji atau '
'honorarium dan tunjangan untuk tahun buku 2026 serta '
'tantiem untuk tahun buku 2025',
'votes_abstain': '0',
'votes_against': '0',
'votes_for': '3372014400',
'votes_in_favor_total': '3372014400'},
{'approved': True,
'pct_abstain': '0',
'pct_against': '0',
'pct_for': '100',
'pct_in_favor_total': '100',
'resolution_items': [],
'resolution_text': 'Menyetujui penggunaan Laba Bersih Perseroan '
'tahun buku 2025 sebesar sebesar Rp '
'5.565.549.359,- (lima milyar lima ratus enam '
'puluh lima juta lima ratus empat puluh '
'sembilan ribu tiga ratus lima puluh sembilan '
'rupiah), sebagai berikut: 1. Sebesar Rp '
'3.500.000.000,- (tiga milyar lima ratus juta '
'rupiah) akan dialokasikan dan dibukukan '
'sebagai dana cadangan; Sedangkan akumulasi '
'laba bersih sampai dengan tahun buku 2025 '
'sebesar Rp 28.523.657.432,- (dua puluh '
'delapan milyar lima ratus dua puluh tiga juta '
'enam ratus lima puluh tujuh ribu empat ratus '
'tiga puluh dua rupiah) akan dibukukan sebagai '
'laba ditahan, untuk menambah modal kerja '
'Perseroan 2. Memberikan kuasa dan wewenang '
'kepada Direksi dan/atau Dewan Komisaris '
'Perseroan untuk melakukan semua dan setiap '
'tindakan yang diperlukan sehubungan dengan '
'keputusan tersebut di atas, sesuai dengan '
'peraturan perundang-undangan yang berlaku. '
'PT. MULTI MEDIKA INTERNASIONAL, Tbk. iii.',
'seq': 2,
'votes_abstain': '0',
'votes_against': '0',
'votes_for': '3372014400',
'votes_in_favor_total': '3372014400'},
{'approved': True,
'pct_abstain': '0',
'pct_against': '0',
'pct_for': '100',
'pct_in_favor_total': '100',
'resolution_items': [],
'resolution_text': 'Menyetujui penetapan Gaji dan/atau honorarium '
'dan/atau remunerasi dan/atau tunjangan '
'lainnya bagi masing-masing anggota Direksi '
'dan anggota Dewan Komisaris perseroan serta '
'pemberian wewenang dan kuasa kepada Dewan '
'Komisaris Perseroan untuk menetapkan gaji '
'dan/atau honorarium dan/atau remunerasi '
'dan/atau tunjangan lainnya bagi masing-masing '
'anggota Direksi Perseroan dan Dewan Komisaris '
'untuk tahun buku 2026 dan tantiem untuk tahun '
'buku 2025 kepada anggota Direksi dan Dewan '
'Komisaris Perseroan iv.',
'seq': 3,
'votes_abstain': '0',
'votes_against': '0',
'votes_for': '3372014400',
'votes_in_favor_total': '3372014400'},
{'approved': True,
'pct_abstain': '0',
'pct_against': '0',
'pct_for': '100',
'pct_in_favor_total': '100',
'resolution_items': [],
'resolution_text': 'Menyetujui pemberian Kuasa kepada Dewan '
'Komisaris Perseroan untuk menunjuk Kantor '
'Akuntan Publik untuk mengaudit atas buku-buku '
'Perseroan untuk Tahun Buku yang akan berakhir '
'pada tanggal 31 Desember 2026 sekaligus '
'memberikan kuasa kepada Direksi Perseroan '
'untuk menetapkan honorarium dan '
'persyaratan-persyaratan lain sehubungan '
'dengan penunjukan Kantor Akuntan Publik '
'tersebut PT. MULTI MEDIKA INTERNASIONAL, Tbk. '
'v.',
'seq': 4,
'votes_abstain': '0',
'votes_against': '0',
'votes_for': '3372014400',
'votes_in_favor_total': '3372014400'},
{'approved': True,
'pct_abstain': '0',
'pct_against': '0',
'pct_for': '100',
'pct_in_favor_total': '100',
'resolution_items': ['Meeting Day and Date : Friday, June 26, '
'2026',
'Meeting Venue : Royal Mediterania Garden '
'Apartment',
'Meeting Time : 4:05 PM WIB to 4:51 PM WIB'],
'resolution_text': '1. Menyetujui tindakan Perseroan untuk '
'penyesuaian maksud dan tujuan serta kegiatan '
'usaha dalam anggaran dasar Perseroan, agar '
'disesuaikan dengan KBLI 2025. 2. Menyetujui '
'pemberian wewenang dan kuasa dengan hak '
'substitusi kepada setiap anggota Direksi '
'Perseroan untuk melakukan segala tindakan '
'sehubungan dengan penyesuaian kbli perseroan '
'menjadi kode kbli tahun 2025, sebagaimana '
'disebutkan di atas, termasuk tetapi tidak '
'terbatas untuk membuat atau meminta untuk '
'dibuatkan serta menandatangani segala akta '
'sehubungan dengan perubahan kode kbli untuk '
'disesuaikan dengan kode kbli 2025, tersebut '
'dan untuk mendaftarkan penyesuaian kode kbli '
'2025 tersebut kepada instansi pemerintah '
'sesuai dengan ketentuan perundang-undangan '
'yang berlaku. PT. MULTI MEDIKA INTERNASIONAL, '
'Tbk. ANNOUNCEMENT OF SUMMARY MINUTES OF '
'ANNUAL GENERAL MEETING OF SHAREHOLDERS PT '
'MULTI MEDIKA INTERNASIONAL, Tbk PT MULTI '
'MEDIKA INTERNASIONAL, Tbk, a limited '
'liability company listed on the Indonesia '
'Stock Exchange, domiciled in West Jakarta '
'(hereinafter referred to as the "Company"), '
'hereby announces to all Shareholders that on '
'Friday, June 26, 2026, the Company held an '
'Extraordinary Annual General Meeting of '
'Shareholders (hereinafter referred to as the '
'"Meeting"). as regulated in Article 49 of '
'Financial Services Authority Regulation No. '
'Pursuant to OJK Regulation No. '
'15/POJK.04/2020 concerning the Planning and '
'Implementation of the General Meeting of '
'Shareholders of Public Companies on April 20, '
'2020 ("OJK Regulation No. 15"), the Company '
'is required to prepare a summary of the '
'minutes of the Meeting, in accordance with '
'the minutes of the Meeting required in the '
'Deed of Minutes of the Annual General Meeting '
'of Shareholders of PT Multi Medika '
'Internasional, Tbk No. 123 dated June 26, '
'2026, drawn up by Dr. Sugih Haryati, SH, '
'M.Kn, Notary in South Jakarta, as follows: - '
'Location, Venue, and Date: • Meeting Day and '
'Date : Friday, June 26, 2026 • Meeting Venue '
': Royal Mediterania Garden Apartment '
'Residence, Balai Warga Room, LG Floor, Jl. '
'General S. Parman, Kaveling 28, Tanjung Duren '
'Selatan Village, Grogol Petamburan District, '
'West Jakarta & Electronic General Meeting '
'System (eASY.KSEI) Facilities • Meeting Time '
': 4:05 PM WIB to 4:51 PM WIB - Meeting '
"Agenda: 1. Approval of the Company's Annual "
'Report, including the Financial Statements '
"and the Board of Commissioners' Supervisory "
'Report for the Fiscal Year ending December '
'31, 2025; 2. Approval and Determination of '
"the Use of the Company's Net Profit for the "
'Financial Year Ending December 31, 2025 3. '
'Determination of the Salaries or Honorariums '
'and Allowances for the Financial Year 2026, '
'as well as Bonuses for the Financial Year '
"2025, for the members of the Company's Board "
'of Directors and Board of Commissioners. 4. '
'Appointment of a Public Accountant and/or '
"Public Accounting Firm to audit the Company's "
'financial statements for the financial year '
'ending December 31, 2026. 5. Approval of the '
"Adjustment of the Company's KBLI to the 2025 "
"KBLI Code. 3. - Members of the Company's "
'Board of Directors present at the Meeting: '
'President Director Director PT. MULTI MEDIKA '
"INTERNASIONAL, Tbk. Members of the Company's "
'Board of Commissioners present at the '
'Meeting: President Commissioner Independent '
'Commissioner 4. The number of shares with '
'valid voting rights present at the Meeting '
'was 3,372,014,400 (three billion three '
'hundred and seventy-five thousand Rupiah). '
'twenty-two million fourteen thousand four '
'hundred) shares or equivalent to 70.24% '
'(seventy point two four percent) of the total '
'number of shares with valid voting rights '
'issued by the Company. That the attendance '
'quorum required for holding the Meeting and '
'implementing the First, Second, Third, and '
'Fourth Meeting agenda items based on Article '
'23 paragraph 1 letter a number (i) of the '
'Articles of Association in conjunction with '
'Article 41 paragraph 1 letter a of OJK '
'Regulation No. 15/POJK.04/2020, is that the '
'Meeting is held by Shareholders and their '
'proxies who are more than 1/2 (one half) of '
'the total shares with voting rights present '
'or vice versa, while for the Fifth Meeting '
'agenda item based on Article 23 paragraph 1 '
'letter b number of the Articles of '
'Association in conjunction with Article 42 '
'letter a of OJK Regulation No. In accordance '
'with Article 15/POJK.04/2020, the Meeting was '
'attended by Shareholders and their proxies '
'representing more than 2/3 (two-thirds) of '
'the total shares with voting rights, and '
'since the quorum for all Meeting agenda items '
'was present, the Meeting was valid and '
'lawful. 5. Shareholders were given the '
'opportunity to ask questions and/or provide '
'opinions regarding each Meeting agenda item. '
'For the first meeting agenda item, there was '
'a question, but it was not in accordance with '
'the meeting agenda and therefore did not '
'require an answer from the Board of '
'Directors. 6. The results of the '
'decision-making process, which was carried '
'out by voting, and the Meeting Resolutions '
'are as follows: i. First Agenda Item Disagree '
'Agree (Majority Vote + Abstain) 0 votes/0 % '
'3.372.014.400 votes 0 votes 0 % 3.372.014.400 '
'votes /100% Meeting Resolutions: To approve '
"the Company's Annual Report for the 2025 "
'Financial Year, including the Board of '
"Commissioners' Supervisory Report, and to "
"ratify the Company's Financial Statements for "
'the 2025 Financial Year, audited by the '
'Public Accounting Firm Hadori Sugiarto Adi & '
'Rekan. To grant full release and discharge '
'(acquit et de charge) to all members of the '
"Company's Board of PT. MULTI MEDIKA "
'INTERNASIONAL, Tbk. Directors for their '
"actions, and to all members of the Company's "
'Board of Commissioners for their supervision '
"during the Company's financial year ending "
'December 31, 2025. ii. Second Agenda Disagree '
'Agree (Majority Vote + Abstain) 0 votes/0 % '
'3.372.014.400 votes 0 votes 0 % 3.372.014.400 '
'votes /100% Meeting Resolutions: To approve '
"the use of the Company's Net Profit for the "
'2025 financial year in the amount of Rp '
'5,565,549,359 (five billion five hundred '
'sixty-five million five hundred forty-nine '
'thousand three hundred fifty-nine rupiah), as '
'follows: 1. Rp 3,500,000,000 (three billion '
'five hundred million rupiah) will be '
'allocated and recorded as a reserve fund; '
'Meanwhile, the accumulated net profit up to '
'the 2025 financial year of IDR 28,523,657,432 '
'(twenty-eight billion five hundred '
'twenty-three million six hundred fifty-seven '
'thousand four hundred and thirty-two rupiah) '
'will be recorded as retained earnings to '
"increase the Company's working capital. 2. "
"Granting power and authority to the Company's "
'Board of Directors and/or Board of '
'Commissioners to take all and any necessary '
'actions in connection with the aforementioned '
'decision, in accordance with applicable laws '
'and regulations. iii. Third Agenda Item '
'Disagree Agree (Majority Vote + Abstain) 0 '
'votes/0 % 3.372.014.400 votes 0 votes 0 % '
'3.372.014.400 votes /100% Meeting '
'Resolutions: To approve the determination of '
'salaries and/or honorariums and/or '
'remuneration and/or other allowances for each '
"member of the Company's Board of Directors "
'and Board of Commissioners, and to grant '
"authority and power to the Company's Board of "
'Commissioners to determine the salaries '
'and/or honorariums and/or remuneration and/or '
'other allowances for each member of the '
"Company's Board of Directors and Board of "
'Commissioners for the 2026 financial year and '
'bonuses for the 2025 financial year for each '
"member of the Company's Board of Directors "
'and Board of Commissioners. PT. MULTI MEDIKA '
'INTERNASIONAL, Tbk. iv. Fourth Agenda Item; '
'Disagree Agree (Majority Vote + Abstain) 0 '
'votes/0 % 3.372.014.400 votes 0 votes 0 % '
'3.372.014.400 votes /100% Meeting '
'Resolutions: Approved the granting of power '
"of attorney to the Company's Board of "
'Commissioners to appoint a Public Accounting '
"Firm to audit the Company's books for the "
'Financial Year ending December 31, 2026, and '
"also authorized the Company's Board of "
'Directors to determine the honorarium and '
'other requirements related to the appointment '
'of the Public Accounting Firm. ',
'seq': 5,
'votes_abstain': '0',
'votes_against': '0',
'votes_for': '3372014400',
'votes_in_favor_total': '3372014400'}],
'is_electronic': True,
'meeting_date': '2026-06-26',
'meeting_type': 'AGM',
'pct_present': '70.24',
'shares_present': '3372014400',
'time_end': '16:51:00',
'time_start': '16:05:00',
'venue': 'Apartemen Royal Mediterania Garden Residence, Ruang Balai Warga '
'Lantai LG, Jl. Jenderal S Parman Kaveling 28, Kelurahan Tanjung '
'Duren Selatan, Kecamatan Grogol Petamburan, Jakarta Barat & '
'Fasilitas Electronic General Meeting System (‘eASY.KSEI’) •'}